Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL SELF INJECTION DEVICE INDUSTRY
2.1 Summary about Self Injection Device Industry
2.2 Self Injection Device Market Trends
2.2.1 Self Injection Device Production & Consumption Trends
2.2.2 Self Injection Device Demand Structure Trends
2.3 Self Injection Device Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Reusable Self Injection Device
4.2.2 Disposable Self Injection Device
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Insulin Injection
4.3.2 Epinephrine Injection
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Reusable Self Injection Device
5.2.2 Disposable Self Injection Device
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Insulin Injection
5.3.2 Epinephrine Injection
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Reusable Self Injection Device
6.2.2 Disposable Self Injection Device
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Insulin Injection
6.3.2 Epinephrine Injection
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Reusable Self Injection Device
7.2.2 Disposable Self Injection Device
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Insulin Injection
7.3.2 Epinephrine Injection
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Reusable Self Injection Device
8.2.2 Disposable Self Injection Device
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Insulin Injection
8.3.2 Epinephrine Injection
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Reusable Self Injection Device
9.2.2 Disposable Self Injection Device
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Insulin Injection
9.3.2 Epinephrine Injection
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Novo Nordisk
10.1.2 Mylan
10.1.3 Pfizer
10.1.4 Sanofi
10.1.5 BD
10.1.6 Eli Lilly
10.1.7 Gerresheimer
10.1.8 Dongbao
10.1.9 Ypsomed
10.1.10 Owen Mumford
10.1.11 Antares Pharma
10.1.12 Haselmeier
10.2 Self Injection Device Sales Date of Major Players (2017-2020e)
10.2.1 Novo Nordisk
10.2.2 Mylan
10.2.3 Pfizer
10.2.4 Sanofi
10.2.5 BD
10.2.6 Eli Lilly
10.2.7 Gerresheimer
10.2.8 Dongbao
10.2.9 Ypsomed
10.2.10 Owen Mumford
10.2.11 Antares Pharma
10.2.12 Haselmeier
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Self Injection Device Product Type Overview
2.Table Self Injection Device Product Type Market Share List
3.Table Self Injection Device Product Type of Major Players
4.Table Brief Introduction of Novo Nordisk
5.Table Brief Introduction of Mylan
6.Table Brief Introduction of Pfizer
7.Table Brief Introduction of Sanofi
8.Table Brief Introduction of BD
9.Table Brief Introduction of Eli Lilly
10.Table Brief Introduction of Gerresheimer
11.Table Brief Introduction of Dongbao
12.Table Brief Introduction of Ypsomed
13.Table Brief Introduction of Owen Mumford
14.Table Brief Introduction of Antares Pharma
15.Table Brief Introduction of Haselmeier
16.Table Products & Services of Novo Nordisk
17.Table Products & Services of Mylan
18.Table Products & Services of Pfizer
19.Table Products & Services of Sanofi
20.Table Products & Services of BD
21.Table Products & Services of Eli Lilly
22.Table Products & Services of Gerresheimer
23.Table Products & Services of Dongbao
24.Table Products & Services of Ypsomed
25.Table Products & Services of Owen Mumford
26.Table Products & Services of Antares Pharma
27.Table Products & Services of Haselmeier
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Self Injection Device Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Self Injection Device Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Self Injection Device Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Self Injection Device Market Forecast (Million USD) Share by Demand 2021f-2026f